Biomarkers for glioma immunotherapy: the next generation.
Ontology highlight
ABSTRACT: The term "biomarker" historically refers to a single parameter, such as the expression level of a gene or a radiographic pattern, used to indicate a broader biological state. Molecular indicators have been applied to several aspects of cancer therapy: to describe the genotypic and phenotypic state of neoplastic tissue for prognosis, to predict susceptibility to anti-proliferative agents, to validate the presence of specific drug targets, and to evaluate responsiveness to therapy. For glioblastoma (GBM), immunohistochemical and radiographic biomarkers accessible to the clinical lab have informed traditional regimens, but while immunotherapies have emerged as potentially disruptive weapons against this diffusely infiltrating, heterogeneous tumor, biomarkers with strong predictive power have
SUBMITTER: Sims JS
PROVIDER: S-EPMC4498992 | biostudies-literature | 2015 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA